Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT05178472
Recruiting
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
for
B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT07097363
Phase2, Recruiting
Phase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)
for
Clear Cell Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07187778
Phase2, Recruiting
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
Location: Boston MA, New Haven CT, Durham NC, Chicago IL,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT06116110
Recruiting
Interested in new pancreatic cancer trials?
Get alerts for new trials in your area by subscribing now
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Philadelphia PA, Wilmington DE, Baltimore MD, Miami FL,
Sponsor: Children's Oncology Group
Sex: All
Age: 2 - 18
Code: NCT05711667
Phase3, Recruiting
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
for
Renal Cell Carcinoma
Location: Boston MA, New York NY, Philadelphia PA, Nashville TN,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07195682
Phase1, Recruiting
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
for
Metastatic Renal Cell Carcinoma,
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center
Sex: All
Age: 18+
Code: NCT05263050
Phase2, Recruiting
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
for
B-cell Non-Hodgkin Lymphoma
Location: New York NY, Jacksonville FL, Franklin TN, Rochester MN
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07123454
Phase1, Phase2, Recruiting
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
for
Non Hodgkin Lymphoma, Richter Transformation, Multiple Myeloma,
Location: Boston MA, Chapel Hill NC, Columbus OH, Cincinnati OH,
Sponsor: Newave Pharmaceutical Inc
Sex: All
Age: 13+
Code: NCT04771572
Phase1, Recruiting
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells